Biogen expects $34 million charge for research and development expenses.
Share this article
Corporate
Score 25
Neutral
Biogen expects $34 million charge for research and development expenses
Apr 06, 2026 10:43 UTC
BIIB
Short term
Related Articles
Score 25
Riley Gold raises C$1.67M from warrant exercises
Apr 06, 11:51
Score 25
AnalytixInsight Appoints Board Chair as Interim CEO Amid Leadership Transition
Apr 06, 11:50
Score 25
Bullish
Webuy Global launches AI-enabled MICE unit, tops $2M in early transactions
Apr 06, 11:48
Score 25
Bullish
Opus Genetics secures up to $155M financing from Oberland Capital
Apr 06, 11:45
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.